Retrospectives and perspectives of current haematology

Czech version

Authors: M. Penka
Authors‘ workplace: Oddělení klinické hematologie FN Brno, přednosta prof. MUDr. Miroslav Penka, CSc.
Published in: Vnitř Lék 2005; 91(7 a 8): 775-780
Category: 128th Internal Medicine Day - 21rd Vanysek's Day Brno 2005 - Vanysek's Lecture

Overview

Haematology is relatively new branch that has been established as an advanced branch of internal medicine in the beginning of the last century. From the beginning it is characterised by very narrow relationship between clinical and laboratory aspects. Further characteristic feature of haematology is its very deep concentration on research activities and cognition of disease fundamentals in cellular, subcellular and molecular levels and immediate use of these pieces of knowledge in practical medicine. Haematology infiltrates even other branches through important research findings. However this penetration is given by markedly interdisciplinary character of branch polarisation also, as well as by the significance of haematological complications in acute conditions. Haematology achieves highly significant progress in care of patients with wide-spread diseases, such as anaemia, with highly serious diseases, such as leukaemia and haematological malignancies at all, and problematical ones, such as haemorrhagic disorders. Present development anticipates a continuation of tendency of branch rapid expansion including utilisation of the most up-to date research trends, both in the scientific aspect and technical resources.

Key words:
haematology – clinic – laboratory – anaemia – leukaemia – coagulopathy – DIC

Sources

1. Adam Z, Vorlíček J et al. Hematologie II. Přehled maligních hematologických nemocí. Praha: Grada 2001, 21–677.

2. Barbui T, Barosi G, Brossi A et al. Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology

and Italian Group for Bone Marrow Transplantation. Haematologica 2004; 89: 215–232.

3. Barthles M, Schramm W. Gerinnungsfaktorkonzentrate. Haemostaseologie 2004; 4: 286–297.

4. Bick RL. Disseminated Intravascular Coagulation. A Review of Etiology, Pathophysiology, Diagnosis and Management: Guidelines for Care. Clini Appl Thrombosis/Hemostasis 2002; 8: 1–31.

5. Brdička R. Lidský genom na rozhraní tisíciletí. Praha: Grada 2001: 7–249.

6. Colman RW, Hirsh J, Marder VJ et al. Hemostasis and Thrombosis, Basic Principles & Clinical Practice. 4^th ed. Philadelphia: Williams & Wilkins 2000: 3–1578.

7. Donner L. Klinická hematologie. Praha: Avicenum 1985: 5–448.

8. Esmon CT. The Protein C Pathway. Chest 2003; 124: 26–32.

9. Fareed J, Hoppensteadt DA, Bick RL. Management of Thrombotic and Cardiovascular Disorders in the New Millenium. C Appl Thromobsis/Hemostasis 2003; 9: 101–108.

10. Friedmann B. Hematologie v praxi. Praha: Galén 1994: 1–335.

11. Goodnough LT, Lublin DM, Zhang L et al. Transfusion medicine service policies for recombinant factor VIIa administration. Transfusion 2004; 44: 1325–1331.

12. Hettiarachchi LJ, Prins MH, Bueller HR et al. Undiagnosed Malignancy in Patients with Deep Vein Thrombosis, Incidence, Risk factors, and Diagnosis. Cancer 1998; 83: 180–185.

13. Hirsh J, Fuster V, Ansell J et al. American Heart Association/American College of Cardiology Foundation Guide to Warfarin therapy. Ciculation 2003; 107: 1692–1711.

14. Hull RD, Pineo GF, Francis Ch et al. Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin Extended Out-of-Hospital vs In-Hospital Warfarin/Outof-Hospital Placebo in Hip Arthroplasty Patients. Original Investigation. Arch Intern Med 2000; 160: 2208–2215.

15. Hrubišková K. Poruchy hemostázy a hemokoagulácie. Martin: Osveta 1979: 1–208.

16. Kessler P. Léčba orálními antikoagulancii. Praha: Orion-yhtyma Oyj 2002: 1–62.

17. Kovalevsky G, Gracia CR, Berlin JA. Evaluation of the Association Between Hereditary Thrombophilias and Recurrent Pregnancy Loss. A meta–analysis. Arch Intern Med 2004; 164: 558–563.

18. Kubisz P, Hrubišková K, Pařízek M et al. Trombocyty a trombocytopenie. Martin: Osveta 1987: 9–297.

19. Kvasnička J. Trombofilie a trombotické stavy v klinické praxi. Praha: Grada 2003: 13–299.

20. Lee GR, Foerster J, Luken JM et al. Wintrobe’s Clinical Hematology. Vol. 2. 10^th ed. Philadephia: Williams &Wilkins 1999: 1–2763.

21. Levi M. Current understanding of disseminated intravascular coagulation. British Journal of Haematology 2004; 124: 567–576.

22. Mayer J, Starý J et al. Leukemie. Praha: Grada 2002: 1–392.

23. Mesters RM, Mannucci PM, Coppola R. Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood 1996; 88: 881–886.

24. Netoušek M. Nauka o krvi. Praha: Společnost lékařů českých 1949: 9–446.

25. Neuwirt J, Nečas E, Kornalík F et al. Patofyziologie krve. Praha: Avicenum 1983: 5–365.

26. Owen ChA jr. A History of Blood Coagulation. Mayo Foundationfor Medical Education and Research Rochester 2001: 1–355.

27. Pecka M. Laboratorní hematologie v přehledu. Buňka a krvetvorba. Český Těšín: FINIDR 2002: 5–160.

28. Penka M, Buliková A, Matýšková M et al. Hematologie I. Neonkologická hematologie. Praha: Grada 2001: 9–201.

29. Penka M, Buliková A, Matýšková M et al. Diseminovaná intravaskulární koagulace (DIC). Praha: Grada 2003: 9–231.

30. Poller L, Keown M, Chauman N et al. European Concerted Action on Anticoagulation, Correction of displayed international normalized ratio on two pointof-care test whole-blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent international sensitivity index calibration. Br J Haematol

2003; 122: 944–949.

31. Sander S, White CM. Ximelagatran. Formulary 2004; 39: 398–404.

32. Tailor FB jr, Tob CH, Holte K et al. Towards a definition, clinical and laboratory criteria and a scoring system for disseminated intravascular coagulation. Thrombosis and Haemostasis 2000; 86: 1327–1330.

33. Thomas L. Clinical Laboratory Diagnostics. Use and Assessment of Clinical Laboratory Results. Frankfurt: TH-Books 1998: 6–1527.

34. Tefferi A. Primary Hematology. New Jersey: Humana Press 2001: 3–472.

35. Widimský J, Malý J et al. Akutní plicní embolie a žilní trombóza. Praha: Triton 2002: 13–303.